🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to determine the best treatment approach based ...
Status
Not Yet Recruiting
Location
Beth Israel Deaconess Medical Center (BIDMC)
Start Date
2026-06-08
Trial ID
NCT07624513
The primary purpose of this study is to assess the efficacy (overall respon...
Status
Recruiting
Location
Mayo Clinic in Arizona - Phoenix- Site Number : 8400058
Start Date
2025-03-17
Trial ID
NCT06356571
This is a randomized, open-label, parallel, Phase 3 study with 2-arms for t...
Status
Recruiting
Location
North Central Neurology Associates- Site Number : 8401100
Start Date
2026-01-14
Trial ID
NCT07325292
Treatments Being Tested
This research study is investigating the safety and effectiveness of using ...
Status
Recruiting
Location
University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center
Start Date
2022-02-18
Trial ID
NCT05145400
Treatments Being Tested
The main purpose of this study is to evaluate the safety and tolerability o...
Status
Completed
Location
LABCORP
Start Date
2021-09-27
Trial ID
NCT04848402
Treatments Being Tested
The study will test a new combination of 3 drugs: Isatuximab (Isa), Iberdom...
Status
Recruiting
Location
Barts Health Trust
Start Date
2025-06-02
Trial ID
NCT06762769
Treatments Being Tested
This is a randomized, open-label, 2-arm, parallel-group, single-dose, multi...
Status
Completed
Location
Q-Pharm Pty Ltd; Nucleus Network Brisbane Clinic
Start Date
2022-05-30
Trial ID
NCT05275010
The primary objectives of this study are to assess the relative bioavailabi...
Status
Completed
Location
Anaheim Clinical Trials LLC /ID# 222821
Start Date
2020-09-01
Trial ID
NCT05274100
Treatments Being Tested
This is an open-label phase 2 study of elranatamab in combination with isat...
Status
Recruiting
Location
Massachusetts General Hospital
Start Date
2025-08-14
Trial ID
NCT06832865
Treatments Being Tested
The purpose of this open-label, randomized, active-comparator-controlled st...
Status
Recruiting
Location
Brigham & Women's Hospital- Site Number : 8400049
Start Date
2026-03-13
Trial ID
NCT07412470